High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses.

作者: Rosaria Arvia , Fabiana Corcioli , Alberta Azzi

DOI: 10.1016/J.JVIROMET.2013.02.016

关键词: High Resolution MeltGeneticsVirologyGeneVirusOseltamivirInfluenza A virusSanger sequencingMutationPyrosequencingBiology

摘要: Abstract A real-time PCR followed by high resolution melting analysis (HRMA) was developed, for rapid detection of antiviral resistance markers in influenza viruses, both H1N1 and H3N2 subtypes. The targets these assays were the nucleotide substitution G806A (S31N mutation) M gene as marker to adamatanes viruses A(H3N2), A356T (E119V N2 A(H3N2) C823T (H274Y N1 pandemic A(H1N1) 2009 virus oseltamivir resistance. First, designed primers overall protocol HRMA validated using already characterized viral isolates either containing or lacking changes at tested codons. Then, used search 75 clinical samples, positives, analyzed previously pyrosequencing Sanger sequencing, adamantane-derivatives 57 positive samples. results agreement with those obtained sequencing. As regards isolates, revealed a widespread adamantanes 89.5% G806A, while 3% resistant (A356T change). HRMA, applied drugs against confirmed be procedure flexible, low cost time-saving, suitable application epidemiological surveys settings diagnostic purposes.

参考文章(34)
Guy Boivin, Fred Y. Aoki, Noel Roberts, Influenza virus susceptibility and resistance to oseltamivir. Antiviral Therapy. ,vol. 12, pp. 603- 616 ,(2007)
R Pebody, A Lackenby, C Moore, J Ellis, M Galiano, M Zambon, J McMenamin, P Muir, A Bermingham, M Guiver, S Miah, CI Thompson, I Vipond, A Reynolds, J Moran Gilad, S Bolotin, R Gunson, L Calatayud, Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Eurosurveillance. ,vol. 16, pp. 19784- ,(2011) , 10.2807/ESE.16.05.19784-EN
H. K. Lee, C. K. Lee, T. P. Loh, J. W.-T. Tang, P. A. Tambyah, E. S.-C. Koay, High-Resolution Melting Approach to Efficient Identification and Quantification of H275Y Mutant Influenza H1N1/2009 Virus in Mixed-Virus-Population Samples Journal of Clinical Microbiology. ,vol. 49, pp. 3555- 3559 ,(2011) , 10.1128/JCM.01087-11
Angie Lackenby, Catherine I Thompson, Jane Democratis, The potential impact of neuraminidase inhibitor resistant influenza. Current Opinion in Infectious Diseases. ,vol. 21, pp. 626- 638 ,(2008) , 10.1097/QCO.0B013E3283199797
PM Colman, Zanamivir: an influenza virus neuraminidase inhibitor. Expert Review of Anti-infective Therapy. ,vol. 3, pp. 191- 199 ,(2005) , 10.1586/14787210.3.2.191
Mathilde Richard, Claire Deléage, Mendy Barthélémy, Yi Pu Lin, Alan Hay, Bruno Lina, Olivier Ferraris, Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors Journal of Clinical Virology. ,vol. 41, pp. 20- 24 ,(2008) , 10.1016/J.JCV.2007.10.021
Rosaria Arvia, Fabiana Corcioli, Lisa Simi, Claudio Orlando, Riccardo De Santis, Marzia Facchini, Isabella Donatelli, Alberta Azzi, Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010–2011 Journal of Virological Methods. ,vol. 184, pp. 113- 116 ,(2012) , 10.1016/J.JVIROMET.2012.05.018
Luisa Galli, Alberta Azzi, Elena Chiappini, Fabiana Corcioli, Tommaso Bianconi, Francesco Mannelli, Maurizio de Martino, A Real-Time Reverse Transcriptase-Polymer Chain Reaction To Evaluate Natural History of Viral Shedding in Outpatient Children and Adolescents With Pandemic 2009 Influenza A(H1N1) Chest. ,vol. 138, pp. 456- 457 ,(2010) , 10.1378/CHEST.10-0323
Olivier Ferraris, Bruno Lina, Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. Journal of Clinical Virology. ,vol. 41, pp. 13- 19 ,(2008) , 10.1016/J.JCV.2007.10.020
M.L Herlocher, J Carr, J Ives, S Elias, R Truscon, N Roberts, A.S Monto, Influenza virus carrying an R292k mutation in the neuraminidase gene is not transmitted in ferrets Antiviral Research. ,vol. 54, pp. 99- 111 ,(2002) , 10.1016/S0166-3542(01)00214-5